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Abstract
Spirometry and exhaled nitric oxide are two important complimentary tools to identify 
and assess asthma control in children. We aimed to determine the ability of a new sug-
gested spirometry- adjusted fraction of exhaled nitric oxide (NO) index in doing that. A 
random sample of 1602 schoolchildren were screened by a health questionnaire, skin 
prick tests, spirometry with bronchodilation and exhaled NO. A total of 662 children 
were included with median (IQR) exhaled NO 11(14) ppb. Receiver operating charac-
teristic (ROC) curves using exhaled NO equations from Malmberg, Kovesi and 
Buchvald, and spirometry- adjusted fraction of exhaled NO values were applied to 
identify asthmatic children and uncontrolled asthma. Receiver operating characteristic 
(ROC) curves failed to identify asthmatic children (all AUC < 0.700). Spirometry- 
adjusted fraction of exhaled NO/FEV1 (AUC = 0.712; P = .010) and NO/FEF25%-75% 
(AUC = 0.735 P = .004) had a fair and increased ability to identify uncontrolled disease 
compared with exhaled NO (AUC = 0.707; P = .011) or the Malmberg equation 
(AUC = 0.701; P = .014). Sensitivity and specificity identifying non- controlled asthma 
were 59% and 81%, respectively, for the cut- off value of 9.7 ppb/L for exhaled 
NO/FEV1, and 40% and 100% for 15.7 ppb/L/s for exhaled NO/FEF25%-75%. Exhaled 
NO did not allow to identify childhood asthma. Spirometry- adjusted fraction of ex-
haled NO performed better- assessing asthma control in children. Thus, although more 
validation studies are needed, we suggest its use in epidemiological studies to assess 
asthma control.
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1  | BACKGROUND
Exhaled nitric oxide (NO) has been used as non- invasive, easy to 
measure, reproducible and immediately available biomarker of air-
way inflammation in allergic diseases.1 Standardized procedures for 
its measurement2 and clinical use3 have already been published, with 
a strong level of evidence in the diagnosis of eosinophilic airway in-
flammation and for monitoring airway inflammation in patients with 
asthma.3 In fact, the expression of inducible nitric oxide synthe-
tase mRNA has been shown to be increased in the airways of sub-
jects with asthma4 and to be downregulated by the use of inhaled 
steroids.5
     |  755MARTINS eT Al.
Although the diagnostic accuracy of exhaled NO in the identifica-
tion of asthma in children is moderate, it suggests that it might be a 
promising tool6 and the confounding or effect modification of atopy is 
believed to be a key feature that limits the usefulness of exhaled NO 
in asthma diagnosis.
Exhaled nitric oxide has shown to be efficient in guiding med-
ication management, as a reduction of 20% in exhaled NO is con-
sidered indicative of a response to anti- inflammatory therapy.3 
However, no significant advantage was seen with the specific use of 
exhaled NO- driven protocols to guide asthma treatment compared 
with other methods,7,8 and according to GINA guidelines,9 treat-
ment of asthmatic children usually relies on symptoms reported by 
the child and/or guardians. Furthermore, correlations between air-
way inflammation and symptoms, asthma control and asthma sever-
ity are weak or absent.1,9-11 In steroid- naïve patients, high exhaled 
NO levels predict a good response to inhaled corticosteroids (ICS) 
treatment, and a low level of exhaled NO in adults in ICS treatment 
is associated with reduced likelihood ratio of exacerbation.12 Until 
now, it is not possible to provide clear recommendations for the 
utility of the exhaled NO in asthma management, as studies failed 
to show an overall benefit in the rate of exacerbations as well as in 
asthma control, lung function and use of oral corticosteroids during 
exacerbations.13 In a recent study, exhaled NO was used in rela-
tion to FEV1 (exhaled NO/FEV1) to distinguish patients with asthma 
from those without with promising results.14 This kind of approach 
could be a way to minimize the influence of baseline bronchial con-
striction on exhaled NO.
With this study, we aimed to assess the ability of spirometry- 
adjusted fraction of exhaled nitric oxide to identify and assess asthma 
control in children, in comparison with traditional approaches.
2  | METHODS
2.1 | Study design
This study is a cross- sectional analysis of data of 1602 children, aged 
between 8 and 12 years. Assessments were carried out between 
January and May of 2014 and 2015 (Data S1). The questionnaire in-
cluded previous and current respiratory symptoms, questions about 
congenital anomalies, systemic diseases, long- term medication and 
environmental exposure.
2.2 | Assessments
All the participants completed anthropometric measurements. Skin 
prick tests were performed on the forearm using a QuickTestTM ap-
plicator containing house dust mite, mix of weeds, mix of grasses, 
cat dander, dog dander and Alternaria alternata, negative and a 
positive controls (Hall Allergy, Netherlands). Exhaled NO was ana-
lysed using a NOBreath® (Bedfont® Scientific Ltd, Maidstone, UK). 
Spirometry was carried out using Spirolab spirometer (MIR, Italy) and 
the WINSPIROPRO® software. Reversibility testing was performed 
using four separate doses of 100 μg salbutamol through a space 
chamber- coupled MDI. A detailed description of assessment methods 
is presented in the online repository.
2.3 | Definitions and participants
Current asthma was defined as symptomatic children (wheezing in 
the last 12 months, or wheezing with exercise, or waking at night 
with wheezing in the last months, or coughing at night in the last 
12 months or coughing more than 3 months in the last year) with 
reported medical diagnosis or evidence of airway reversibility.15 
Uncontrolled asthma was defined as an increase of at least 12% of 
the forced expiratory volume in 1- second (FEV1) after bronchodila-
tion test or respiratory symptoms in the previous weeks with exhaled 
NO levels higher than 35 ppb.16 The control group was composed by 
all included participants who do not meet the asthma group inclusion 
criteria.
2.4 | Statistical analysis
Data were presented as a mean (SD), median and interquartile range 
(IQR) or proportions accordingly to the type of data. Two- sample t test 
or Mann- Whitney was used to compare data between groups when 
appropriate, and chi- square test to compare proportions. Receiver op-
erating characteristic (ROC) analysis was performed, in order to evalu-
ate the ability of exhaled NO to detect children with asthma and to 
detect uncontrolled asthma. Agreement between ATS classification 
and a measure of control defined by our composite scores with ex-
haled NO adjusted for FEV1 or FEF25%-75% was assessed by Cohen’s 
kappa coefficient. IBM SPSS Statistics for Windows (Version 21.0. 
Armonk, NY, USA: IBM Corp.) was used for data analysis and for draw-
ing graphs. All statistical data with P < .05 were considered significant.
2.5 | Ethics statement
Data collection was approved by the University Ethics Committee, 
and a written informed consent was obtained from each participant 
caregiver.
3  | RESULTS
Exclusion criteria were inability to correctly perform spirometry or 
exhaled NO manoeuvres, incomplete responses to the questionnaire, 
refuse to perform skin prick tests by children or guardians.
A total of 662 children were enrolled (Data S1), 74 (11.2%) were 
included in the asthma group, and a positive bronchodilation test was 
found in 52 (8.0%). Atopic children represented about a third (35.3%) 
of the included participants and presented significantly higher exhaled 
NO levels when compared to non- atopic (Table 1).
The accuracy of absolute values of exhaled NO (AUC = 0.620, 
P = .001), as well as of the Malmberg (AUC = 0.620, P = .001) and 
Kovesi (AUC = 0.621, P = .001) predicted values, was poor to identify 
asthmatic children (Fig. S2). Using the low, normal or high score values, 
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according to Buchvald classification, exhaled NO failed to do it with an 
even lower AUC (AUC = 0.595, P = .008). In non- atopic children, the 
diagnostic power of exhaled NO and all predictive equations failed to 
identify asthma, with AUC’s ranging between 0.500 and 0.600, while 
in atopics, a small but significant improvement was seen (AUC ranged 
from 0.600 to 0.650).
Precision to distinguish between asthmatic and non- asthmatic 
children was improved when exhaled NO adjusted for spirometry was 
used, as shown in Figure 1. The best ratios to identify asthma were 
exhaled NO/FEF25%-75% (AUC = 0.652, P < .001) and exhaled NO/
FEF75% (AUC = 0.646, P < .001). Moreover, when analysing atopic and 
non- atopic participants, results did not differ.
To identify uncontrolled asthma, only absolute values of ex-
haled NO (AUC = 0.707, P = .011) and the Malmberg equation 
(AUC = 0.701, P = .014) allowed to distinguish between controlled 
and non- controlled patients, as shown in Figure 2. Using the 
spirometry- adjusted fraction of exhaled NO allowed us to identify 
uncontrolled asthma with a fair AUC for all ratios: exhaled NO/FEV1 
(AUC = 0.712, P = .010), exhaled NO/FEF25%-75% (AUC = 0.735, 
P = .004), exhaled NO/FEF75% (AUC = 0.733, P = .004) and ex-
haled NO/PEF (AUC = 0.709, P = .011) (Figure 3). When consider-
ing only the non- atopic children with asthma (n = 41), ROC curves 
performed even better, obtaining AUC of 0.744 (P = .028) for FEV1, 
AUC = 0.765 (P = .010) for FEF25%-75%, AUC = 0.762 (P = .011) 
for FEF75 and AUC = 0.720 (P = .033) for PEF. In the atopic group 
(n = 32), none of the exhaled NO adjusted for spirometry parameter 
could identify uncontrolled asthma.
The best cut- off values to identify uncontrolled asthma, and their re-
spective specificity and sensibility are presented in Table 2. Exhaled NO 
adjusted for FEV1 presented the highest sensitivity in identifying uncon-
trolled asthma, while exhaled NO/FEF25%-75% and exhaled NO/FEF75% 
have the better specificity. When comparing with ATS cut- off levels 
for uncontrolled asthma (>35 ppb), a moderate- to- strong and a weak- 
to- moderate agreements with exhaled NO/FEF25%-75% (>15.7 ppb/L/s) 
and exhaled NO/FEV1 (> 9.72 ppb/L) were seen, respectively, Κ = 0.771 
(95%CI, 0.689- 0.853) and Κ = 0.541 (95% CI, 0.454- 0.628) (Fig.S3).
Total 
n = 662
Atopic 
n = 234
Asthmatic 
n = 74 P value
Ageyears, mean (SD) 8.7 (0.8) 8.7 (0.8) 8.7 (0.8) >.05
Male sex, n (%) 318 (48.0%) 107 (45.7%) 27 (36.5%) <.05
BMI kg/m2, median 
(IQR)
17.0 (3.9) 17.5 (4.0) 17.5 (4.3) >.05
Exhaled NO, ppb, 
median (IQR)
11 (14) 14 (20) 17 (30) <.05
FVCL, mean (SD) 1.91 (0.33) 1.90 (0.33) 1.83 (0.33) <.05
FEV1L, mean (SD) 1.76 (0.28) 1.75 (0.28) 1.65 (0.30) <.05
FEF25%-75%L/s, mean 
(SD)
2.33 (0.55) 2.28 (0.56) 2.09(0.62) <.05
FEV1/FVC, mean (SD) 92.4 (5.3) 92.1 (5.4) 90.5 (6.2) <.05
Cough ≥ 3/mo last year 3.8% (23) 3.6% (8) 14.3% (10) <.05
Cough in previous 3 mo 35.6% (236) 40.2% (94) 48.6% (36) <.05
Wheezing ≥ 4 times last 
year
8.9% (15) 9.8% (6) 25.0% (10) <.05
Awakenings > 1/mo 
with wheeze
19.7% (31) 23.2% (13) 50.0% (20) <.05
Positive Bronchodilation 7.9% (52) 9.4% (22) 60.8% (45) <.05
Exhaled NO/FVC ppb/L 
median (IQR)
5.76 (6.54) 7.38 (12.70) 8.97 (15.38) <.05
Exhaled NO/FEV1 ppb/L 
median (IQR)
6.30 (7.31) 8.14 (13.82) 9.72 (17.06) <.05
Exhaled NO/FEF25%-
75% ppb/L/s median 
(IQR)
4.63 (5.88) 5.93 (11.01) 8.36 (16.41) <.05
Exhaled NO/
FEF75% ppb/L/s median 
(IQR)
8.39 (11.23) 10.92 (20.00) 17.23 (29.01) <.05
Exhaled NO/PEF ppb/
L/s median (IQR)
2.97 (3.58) 3.69 (5.89) 4.89 (8.33) <.05
IQR, interquartile range; SD, standard deviation; the values identified in bold are statistically 
significant.
TABLE  1 Study participants
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4  | DISCUSSION
Our findings provide support to the preferential use of spirometry- 
adjusted fraction of exhaled NO when asthma is suspected and for 
reporting control, by showing its increased performance in epidemi-
ological studies with children. Further, we provide new indices and 
cut- off values that allow to distinguish between controlled and uncon-
trolled asthma in school aged children.
Our study has a few limitations. First, the large number of asth-
matic children in our study being treated with inhaled corticosteroids, 
a well- known modifier of exhaled NO levels17,18 and a high prevalence 
of allergic rhinitis, which is usually correlated with exhaled NO levels. 
F IGURE  1 Receiver operating characteristic (ROC) curves for asthma diagnosing using: (A) exhaled NO adjusted for FEV1 (AUC = 0.640, 
P < .001); (B) exhaled NO adjusted for FEF25%-75% (AUC = 0.652, P < .001); (C) exhaled NO adjusted for FEF75% (AUC = 0.646, P < .001); (D) 
exhaled NO adjusted for PEF (AUC = 0.639, P < .001)
eNO/FEV1 eNO/FEF25-75%
eNO/FEF75% eNO/PEF
(A) (B)
(C) (D)
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Secondly, our evaluations were conducted during pollen season, con-
tributing to high exhaled NO levels, even when asthma was not present, 
in pollen allergic patients.19 Thirdly, the use of respiratory symptoms 
with high levels of exhaled NO as a definition of uncontrolled asthma, 
and the subsequent evaluation of an association with exhaled NO ratio 
may lead to a risk of circular reasoning. Nonetheless, this effect will 
also affect the other indices and equations in the same way. Finally, the 
use of airway reversibility as a marker of uncontrolled asthma. During 
asthma management the presence of airway reversibility does not sup-
port stepping down treatment, which would be done if disease was 
under control. Also, a recent study by Heffler and colleagues showed 
bronchodilator response to be a marker of poor controlled asthma.16
F IGURE  2 Receiver operating characteristic (ROC) curves for asthma control using: (A) absolute exhaled NO values (AUC = 0.707, P = .011); 
(B) per cent predicted of Malmberg values (AUC = 0.701, P = .014); (C) per cent predicted of Kovesi values (AUC = 0.698, P = .016); (D) low, 
normal or high values according to Buchvald (AUC = 0.666, P = .043)
Absolute values eNO Malmberg
Kovesi Buchvald
(A) (B)
(C) (D)
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The ability of exhaled NO to identify asthma in children has shown 
conflicting results; a cut- off value of 19 ppb has been suggested, with 
a sensitivity and specificity of 91% and 87%, respectively, for diag-
nosing mild asthma.20 This was partially supported by a large real- life 
study of school aged children, where levels of exhaled NO above 
15.8 ppb showed to be reliable to identify asthma.21 Nonetheless, a 
different work suggested that exhaled NO was associated with atopy, 
but not asthma.22
The usefulness of spirometry- adjusted fraction of exhaled NO 
has been recently suggested for the diagnosis of asthma in chil-
dren, adolescents and young adults by Grzelewski et al14 Cut- off 
points of 11.00 ppb/L, 12.53 ppb/L and 11.81 ppb/L for the ratios 
F IGURE  3 Receiver operating characteristic (ROC) curves for asthma control using: (A) exhaled NO adjusted for FEV1 (AUC = 0.712, 
P = .010); (B) exhaled NO adjusted for FEF25%-75% (AUC = 0.735, P = .004); (C) exhaled NO adjusted for FEF75% (AUC = 0.733, P = .004); (D) 
exhaled NO adjusted for PEF(AUC = 0.709, P = .011)
eNO/FEV1 eNO/FEF25-75%
eNO/FEF75% eNO/PEF
(A) (B)
(C) (D)
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between exhaled NO and FVC, FEV1, FEF25%-75%, respectively, were 
suggested by the authors for asthma diagnose.14 Our results dif-
fered, as we were not able to apply these indices. This is probably 
related to the studied populations; in Grzelewski et al, all children 
were recruited from an allergy department and had respiratory 
symptoms; our study was a population- based sample that repre-
sented school- age children. Therefore, our asthma prevalence was 
11.2%, similar to the prevalence of Portuguese population, which 
was much lower than the prevalence of 59.7% found in Grzelewski 
study.14
To our knowledge, no studies have yet evaluated the ability of 
spirometry- adjusted fraction of exhaled NO in assessing asthma 
control. Some studies have reported significant differences in ex-
haled NO levels between controlled and uncontrolled asthmatic 
children23 and showed that children with levels below 20 ppb had 
significantly higher scores in Asthma Control Test (ACT) and child- 
ACT (C- ACT).24 Additionally, exhaled NO levels correlated with poor 
asthma control status in inhaled corticosteroids (ICS) untreated 
cases.25 Exhaled NO also proved to be a useful tool that distin-
guishes asthma severity and asthma control in children when FEV1 
fails to do it26 as well as when its defined by a clinical evaluation.27 
Nevertheless, there is also evidence against the use of exhaled NO 
in the assessment of asthma control in children: it does not have 
enough discriminatory value in children under ICS treatment10 and 
disagrees among common measures of asthma control such as the 
C- ACT.28,29
Spirometry- adjusted fraction of exhaled NO had a fair accuracy to 
distinguish between controlled and uncontrolled asthma. We found 
that 78% of the children had uncontrolled disease, defined by an 
increase of at least 12% of the FEV1 after salbutamol or respiratory 
symptoms with exhaled NO level above than 35 ppb. This figure is 
fairly similar to other studies that reported about 75% uncontrolled 
asthma between 5 and 18 years of age.10,23,30,31
In our study, the ratio of exhaled NO/FEF25%-75% arises as the best 
to assess asthma control, while the exhaled NO adjusted for FEV1 as 
the most sensitive. The higher sensitivity of exhaled NO/FEV1 can 
be explained by the use of FEV1 as a gold standard when assessing 
lung function as the main determinant of bronchodilation or bronchial 
challenge tests, as well as in the classification of severity in spiromet-
ric abnormalities and prognostic outcomes in pulmonary obstructive 
diseases. Relatively to exhaled NO/FEF25%-75%, Siroux et al
32 found 
that small airway obstruction, as assessed based on FEF25%-75%, might 
contribute to the long- term persistence of asthma and the subsequent 
risk for poor asthma outcomes, independently from effects of the large 
airways. Our findings may reflect the physiologic dysfunction in the 
clinical expression of asthma control; however, it is not possible to as-
sert whether small airways inflammation also contribute to this clinical 
outcome, as a study with a different methodology, with alveolar and 
exhaled NO in relation to small airways function parameters would be 
a better approach.
A moderate- to- strong agreement between spirometry- adjusted 
fraction of exhaled NO cut- off levels and those from the ATS3 was ob-
served: while exhaled NO/FEF25%-75% identified further 7% (5 of 74) 
of children with uncontrolled asthma that would be missed by the ATS 
cut- off level, the later identified 3% (2 of 74) of children with uncon-
trolled asthma that were not identified by exhaled NO/FEF25%-75%. A 
change of 7% is an important difference when analysing large cohorts 
or epidemiologic studies; therefore, the use of combined measures 
exhaled NO/FEV1 and exhaled NO/FEF25%-75% could provide a best 
approach identifying asthma control. Also, the agreement between 
these two measures is not perfect, so they identify essentially different 
subjects.
Determinants of exhaled NO includes age, sex, body height, 
atopy and smoking status,19,33 but in our study exhaled NO cor-
relates only with age, and in spite of a significant correlation, it 
is weak and was not possible to derive any equation of reference 
values (results not shown). In developing individuals, exhaled NO 
increases until 14 years in females and 16 in males, and similar 
development is observed for anatomic dead space volume.34 This 
finding suggests that the growth dependency in exhaled NO levels 
is probably due to growth- related increase in the airway area pro-
ducing NO. Therefore, the spirometry adjustment could be regarded 
as a way to normalize this growth effect.
The use of the combined value of spirometry parameters and 
exhaled NO improves the diagnostic ability and better reflects dis-
ease control than either one alone. We also found that this exhaled 
NO/spirometry parameters index performs better in the non- atopic 
group to identify uncontrolled asthma. This may be due to a large 
number of false- positive results in the atopic population, which have 
higher values of exhaled NO, even when they achieve asthma con-
trol, as 73% of children with controlled asthma maintained increased 
NO levels.23 We now can conclude that the use of spirometry- 
adjusted fraction of exhaled NO improves asthma identification as 
well as asthma control assessment in school aged children and we 
suggest its use in epidemiological studies to assess children with 
asthma- like symptoms.
Cut- off value Sensitivity (%)
Specificity 
(%)
Exhaled NO/FEV1 9.72 ppb/L 59 81
Exhaled NO/FEF25%- 75% 15.7 ppb/L/s 40 100
Exhaled NO/FEF75% 22.1 ppb/L/s 50 94
Exhaled NO/PEF 5.7 ppb/L/s 52 88
TABLE  2 Cut- off values and respective 
specificity and sensitivity values to identify 
uncontrolled asthma among children with 
asthma
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